Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(11%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
56%
Ph phase_2
1
11%
Ph phase_3
2
22%
Ph phase_1
1
11%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
2(22.2%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(5)
Other(3)

Detailed Status

Completed5
unknown3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (11.1%)
Phase 21 (11.1%)
Phase 32 (22.2%)
N/A5 (55.6%)

Trials by Status

completed556%
unknown333%
recruiting111%

Recent Activity

1 active trials
Showing 5 of 9
recruitingphase_2

Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study

NCT05667701
completednot_applicable

The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A

NCT06101433
completednot_applicable

Isoflavones and Peritoneal Dialysis

NCT04185168
completedphase_1

Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck

NCT02075112
unknownnot_applicable

The Effects of Isoflavones on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients

NCT03773029
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05667701Phase 2

Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study

Recruiting
NCT06101433Not Applicable

The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A

Completed
NCT04185168Not Applicable

Isoflavones and Peritoneal Dialysis

Completed
NCT02075112Phase 1

Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck

Completed
NCT03773029Not Applicable

The Effects of Isoflavones on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients

Unknown
NCT01463436Phase 3

The Effect of Soy Isoflavone Supplementation on Endothelial Function

Completed
NCT00741208Not Applicable

Modification of Asthma With Soy Isoflavone

Completed
NCT00235924Phase 3

Study Assessing the Effects on Endometrium and Breast of Isoflavone in Post Menopausal Women

Unknown
NCT00262184Not Applicable

A Taiwan Isoflavone Multicenter Study (TIMS)

Unknown

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9